Prospective double-blind randomized study on the efficacy and safety of an n-3 fatty acid enriched intravenous fat emulsion in postsurgical gastric and colorectal cancer patients

Table 2 List of subjects who were excluded from per protocol population

Treatment	Reason for premature termination	Treatment duration
Study group (MCT/LCT/n-3)	Subject withdrew consent	1 day
	Subject withdrew from the study due to without pathological evidence of colon cancer	5 days
	Platelet at screening visit was 135 × 10³/uL, < 150 × 10³/uL	8 days
	Subject used incorrect treatment (used MCT/LCT)	1 day
	Patient experienced life-threatening SAE	7 days
	Central venous catheter was removed due to infection	6 days
	Too late for starting PN on day 1 at requested time	1 day
Control group (LCT/MCT)	AE: bilateral ankle pain	1 day
	Subject withdrew consent	1 day
	High fever, suspect central venous catheter infection	3 days
	Subject withdrew consent	1 day
	Acute bowel obstruction developed and patient underwent diversion colostomy and staged surgery	1 day
	Patient experienced life-threatening SAE	7 days
	Subject withdrew consent	1 day

ISSN: 1475-2891